Devices for treatment of impassability of vessels (world market)

2017: Market size is $2.56 billion

In 2017 the size of the market of the medical devices used for elimination of occlusion (impassability) of vessels reached $2.56 billion, counted in Data Bridge Market Research analytical company.

According to forecasts of experts, this market during the period from 2018 to 2025 will grow with the average speed of 5.2% a year and by the end of this interval of time $3.85 billion will be measured.

The market of the equipment for treatment of impassability of vessels for 2017 was estimated at $2.7 billion

Occlusion of arteries is the sharp vascular insufficiency arising at violation of passability or obstruction of vessels therefore delivery of blood to this or that body is broken that leads to failures in its functioning.

In a research main growth drivers of the market of the equipment for treatment of passability of vessels are listed. Among them — increase in number of patients in general and numbers of minimum and invasive vascular transactions, including at the expense of programs of subsidizing of such surgical interventions.

The main barriers on a propagation path of such equipment analysts call problems with an output of products to the commercial market because of strict regulation of the industry of health care and restriction at treatment of chronic  occlusion.

The medical devices used for elimination of occlusion of vessels are used in such areas as cardiology, peripheral vascular diseases, neurology, urology, oncology, gynecology, etc.

Depending on types of the equipment separate;

• devices for removal of occlusion;
• devices for an embolization (embolichesky spirals and liquid embolichesky means);
• ^[1]

Leaders of the considered market analysts call the following companies:

• Terumo Corporation;
• Medtronic;
• Boston Scientific;
• Stryker Corporation;
• Cordis Corporation;
• DePuy Synthes;
•  St. Jude Medical;
• Cook Medical;
• Sirtex;
• Nordian;
• Penumbra;
• Abbott Laboratories;
• Cardinal Health;
• B. Braun;
• Asahi Intecc;
• C.R. Bard;
• Cook Group;
• Angiodynamics;
• Acrostak.

Notes